Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies, immune checkpoint inhibitors are showing particular promise.
Our latest infographic is a snapshot of the PD-1/PD-L1 market at this time.
http://www.researchpartnership.com/news/2016/08/infographic-immunno-oncology/